The DOI matches its Crossref record; 36 of the 37 references it cites were found in a registry or an index.
Cardiovascular Effects of Physiological and Standard Sex Steroid Replacement Regimens in Premature Ovarian Failure
Abstract
Current hormone replacement therapy may not optimize cardiovascular health in women with premature ovarian failure. We compared the effects of physiological and standard sex steroid replacement regimens on cardiovascular health in these women. In an open-label, randomized, controlled crossover trial, 34 women with premature ovarian failure were randomly assigned to 4-week cycles of physiological (transdermal estradiol and vaginal progesterone) and standard (oral ethinylestradiol and norethisterone) therapy for 12 months. Cardiovascular health was assessed by 24-hour ambulatory blood pressure, arterial stiffness, and renal and humoral factors. Eighteen women (19 to 39 years of age) completed the 28-month protocol. Both regimens caused similar suppression of luteinizing hormone and follicle-stimulating hormone and provided symptom relief. In comparison with the standard regimen, physiological sex steroid replacement caused lower mean 24-hour systolic and diastolic blood pressures throughout the 12-month treatment period (ANOVA; P ≤0.0001 for both): systolic blood pressure was 7.3 mm Hg (95% CI: 2.5 to 12.0 mm Hg) and diastolic was 7.4 mm Hg (95% CI: 3.9 to 11.0 mm Hg) lower at 12 months. Although there were no differences in arterial stiffness, physiological sex steroid replacement reduced plasma angiotensin II (ANOVA; P =0.007) and serum creatinine (ANOVA; P =0.015) concentrations without altering plasma aldosterone concentrations. In comparison with a standard regimen, physiological sex steroid replacement in women with premature ovarian failure results in lower blood pressure, better renal function, and less activation of the renin-angiotensin system. These findings have major implications for the future cardiovascular health of young women who require long-term sex steroid replacement therapy.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“There is some evidence that blood pressure may be substantially lower with TD E2 preparations compared to oral ethinyl E2, but this has not been tested specifically in TS.359”
From Clinical practice guidelines for the care of girls and women with Turner syndrome. (2024) · cites this paper as [359]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Writing Group for the Women's Health Initiative Investigators (2002) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.288.3.321 · Cited by 15,889
The Pharmacological Basis of Therapeutics
(1976) · American Journal of Health-System Pharmacy · doi:10.1093/ajhp/33.4.373a · Cited by 9,216
Effect of Estrogen Plus Progestin on Stroke in Postmenopausal Women
Wassertheil-Smoller, S. W., Hendrix, S. L., Limacher, M. C., HEISS, G. M., Kooperberg, C. L., Baird, A. E., Kotchen, T. A., Curb, J. D., Black, H. R., Rossouw, J. E., et al. (2003) · JAMA · doi:10.1001/jama.289.20.2673 · Cited by 1,160
A Clinical Trial of Estrogen-Replacement Therapy after Ischemic Stroke
Viscoli, C. M., Brass, L. M., Kernan, W. N., Sarrel, P. M., Suissa, S., & Horwitz, R. I. (2001) · New England Journal of Medicine · doi:10.1056/nejmoa010534 · Cited by 919
Rocca, W. A., Bower, J. H., Maraganore, D. M., Ahlskog, J. E., Grossardt, B. R., de Andrade, M., & Melton, L. J. (2007) · Neurology · doi:10.1212/01.wnl.0000276984.19542.e6 · Cited by 827
Acute vascular effects of estrogen in postmenopausal women.
Gilligan, D. M., Badar, D. M., Panza, J. A., Quyyumi, A. A., & Cannon, R. O. (1994) · Circulation · doi:10.1161/01.cir.90.2.786 · Cited by 554
Effects of Estrogen Replacement Therapy on the Renin-Angiotensin System in Postmenopausal Women
Schunkert, H., Danser, A. H. J., Hense, H.-W., Derkx, F. H. M., Ku¨rzinger, S., & Riegger, G. A. J. (1997) · Circulation · doi:10.1161/01.cir.95.1.39 · Cited by 438
Age at Natural Menopause and Risk of Cardiovascular Disease
Hu, F. B., Grodstein, F., Hennekens, C. H., Colditz, G. A., Johnson, M., Manson, J. E., ROSNER, B. A., & Stampfer, M. J. (1999) · Archives of Internal Medicine · doi:10.1001/archinte.159.10.1061 · Cited by 414
Postmenopausal Hormone Therapy and Risk of Stroke
Simon, J. A., Hsia, J. A., Cauley, J. A., Richards, C., Harris, F., Fong, J., Barrett-Connor, E. L., & Hulley, S. B. (2001) · Circulation · doi:10.1161/01.cir.103.5.638 · Cited by 402
Cited by
Sorted by citations
Items 101–200 of 206
Management of cardiovascular disease in Turner syndrome
Thomas, J. R., & Yetman, A. T. (2009) · Expert Review of Cardiovascular Therapy · doi:10.1586/erc.09.149 · Cited by 11
Novel Strategies and Targets for the Management of Hypertension
TAYLOR, D. A. H. B., & Abdel‐Rahman, A. A. (2009) · Advances in pharmacology · doi:10.1016/s1054-3589(08)57008-6 · Cited by 12
Dowlut-McElroy, T., & Shankar, R. K. (2022) · Journal of Pediatric and Adolescent Gynecology · doi:10.1016/j.jpag.2022.02.002 · Cited by 11
Kriström, B., Ankarberg-Lindgren, C., Barrenäs, M.-L., Nilsson, K. O., & Albertsson-Wikland, K. (2023) · Frontiers in Endocrinology · doi:10.3389/fendo.2023.1197897 · Cited by 11
Zhang, X., Lu, Y., Wu, S., Zhao, X., Li, S., Zhang, S., & Tan, J. (2022) · Frontiers in Endocrinology · doi:10.3389/fendo.2022.959905 · Cited by 11
Ovarian Insufficiency and Fertility Preservation During and After Childhood Cancer Treatment
Foster, K. L., Lee, D. J., Witchel, S. F., & Gordon, C. M. (2024) · Journal of Adolescent and Young Adult Oncology · doi:10.1089/jayao.2023.0111 · Cited by 11
Pepin, A. N., Chesnokova, A., Pishko, A. M., Gysler, S. M., Martin, C., Smith, E., Kassick, M. E., & Taunk, N. K. (2024) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/j.ijrobp.2024.10.023 · Cited by 10
Hypogonadism in adolescent girls: treatment and long-term effects.
Voutsadaki, K., Matalliotakis, M., & Ladomenou, F. (2022) · Acta bio-medica dell'Ateneo parmense/Acta biomedica · doi:10.23750/abm.v93i5.13719 · Cited by 13
Long-Term Followup of Adolescent and Young Adult Females with Hypergonadotropic Hypogonadism
Tsimaris, P., Vrachnis, N., Iliodromiti, Z., & Deligeoroglou, E. (2011) · International Journal of Endocrinology · doi:10.1155/2012/862892 · Cited by 9
Mamtani, M., Jaisinghani, M. T., Jaiswal, S. G., Pipal, K. V., Patel, A. A., & Kulkarni, H. R. (2021) · PLoS ONE · doi:10.1371/journal.pone.0257390 · Cited by 8
Aromatase inhibition increases blood pressure and markers of renal injury in female rats
Almutlaq, R. N., Newell‐Fugate, A. E., Evans, L. C., Fatima, H., & Gohar, E. Y. (2022) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.00055.2022 · Cited by 8
A current perspective into young female sex hormone replacement: a review
Giordano Imbroll, M., & Gruppetta, M. (2020) · Expert Review of Endocrinology & Metabolism · doi:10.1080/17446651.2020.1816820 · Cited by 7
The impact of progestogens on RAAS – a systematic review
Singer, A., Tropschuh, K., von Gernler, M., Decrinis, C., & Stute, P. (2025) · BMC Women s Health · doi:10.1186/s12905-025-03587-5 · Cited by 7
Female reproductive health in pediatric, adolescent, and young adult cancer survivors
Hoefgen, H. R., Benoît, J., Chan, S. H., Jayasinghe, Y., Lustberg, M. B., Pohl, V., Saraf, A. J., Schmidt, D., & Appiah, L. A. (2023) · Pediatric Blood & Cancer · doi:10.1002/pbc.29170 · Cited by 8
Practical and ethical issues for fertility preservation for children and young people with cancer
Andres, M. M., & Wallace, W. H. (2010) · Paediatrics and Child Health · doi:10.1016/j.paed.2009.10.004 · Cited by 7
Self-citationJiang, H., Bai, W., Wang, W., Zhang, J., Wang, K., Liu, Y., Liu, S., Jia, J., & Qin, L. (2017) · Experimental Gerontology · doi:10.1016/j.exger.2017.02.009 · Cited by 7
Richardson, A., Haridass, S. A., Ward, E., Ayres, J., & Baskind, N. E. (2018) · Post Reproductive Health · doi:10.1177/2053369118811233 · Cited by 9
Mittal, M., Panay, N., Supramaniam, P. R., Savvas, M., Cardozo, L., & Hamoda, H. (2020) · Post Reproductive Health · doi:10.1177/2053369120960960 · Cited by 6
Premature Ovarian Insufficiency
Gunning, M. N., Troìa, L., Janse, F., Luisi, S. V., & Fauser, B. C. J. M. (2020) · Endocrinology · doi:10.1007/978-3-030-14782-2_15 · Cited by 6
Gravholt, C. H. (2013) · Elsevier eBooks · doi:10.1016/b978-0-12-383834-6.00050-1 · Cited by 6
Pubertal induction in girls with Turner Syndrome
Aversa, T., Corica, D., Pepe, G., PAJNO, G. B., Valenzise, M., MESSINA, M. F., & WASNIEWSKA, M. (2022) · Minerva Endocrinology · doi:10.23736/s2724-6507.20.03285-x · Cited by 6
for the Guideline Group, Ortmann, O., Beckermann, M. J., Inwald, E. C., Strowitzki, T., Windler, E. E. T., & Tempfer, C. M. (2021) · Archives of Gynecology and Obstetrics · doi:10.1007/s00404-021-06009-7 · Cited by 5
Use of Hormone Therapy in Women with Early Menopause and Premature Ovarian Insufficiency
Lersten, I. L., Clain, E., & Santoro, N. F. (2020) · Seminars in Reproductive Medicine · doi:10.1055/s-0040-1721719 · Cited by 6
Premature Ovarian Insufficiency: A Review
Gupta, A., Tiwari, P., & Khare, C. (2019) · EMJ Reproductive Health · doi:10.33590/emjreprohealth/19-00041 · Cited by 7
Management of a Girl With Delayed Puberty and Elevated Gonadotropins
McGlacken-Byrne, S. M., Achermann, J. C., & Conway, G. S. (2022) · Journal of the Endocrine Society · doi:10.1210/jendso/bvac108 · Cited by 6
Premature ovarian insufficiency: a syndrome or diagnosis
Татарчук, Т. Ф., Косей, Н. В., & Tutchenko, T. М. (2017) · Reproductive Endocrinology · doi:10.18370/2309-4117.2017.34.16-22 · Cited by 5
Hormone Therapy of Premature Ovarian Failure
Oparil, S. (2009) · Hypertension · doi:10.1161/hypertensionaha.108.128025 · Cited by 5
Primary Ovarian Insufficiency, Bone Health, and Other Outcomes in Adolescents
Cipres, D. T., & Gordon, C. M. (2024) · Obstetrics and Gynecology Clinics of North America · doi:10.1016/j.ogc.2024.08.004 · Cited by 4
Diddhenipothage, S. A. D. M., Beck, K. J., Amiyangoda, C. G. K., Bryce, J., Cima, L., Groote, K. D., Deyanova, Y., Globa, E., Herrmann, G., Juul, A., et al. (2025) · Endocrine Connections · doi:10.1530/ec-24-0477 · Cited by 5
Wang, B., Xu, W., Mei, Z., Yang, W., Meng, X., & An, G. (2024) · Frontiers in Endocrinology · doi:10.3389/fendo.2024.1471548 · Cited by 4
Managing Menopause by Combining Evidence With Clinical Judgment
Flores, V. A., & Pal, L. (2018) · Clinical Obstetrics & Gynecology · doi:10.1097/grf.0000000000000384 · Cited by 4
Pozdnyakova, A. A., Marchenko, L. A., & Рунихина, Н. К. (2019) · Obstetrics Gynecology and Reproduction · doi:10.17749/2313-7347.2018.12.4.037-046 · Cited by 3
Prämature Ovarialinsuffizienz: ESHRE-Leitlinien und aktuelle Studien
Feil, K., Zippl, A. L., & Tóth, B. (2019) · Journal für Gynäkologische Endokrinologie/Österreich · doi:10.1007/s41974-019-0103-y · Cited by 3
Premature ovarian insufficiency – to treat or not to treat?
Загородня, О. С., Венцківська, І. Б., & Kazak, A. (2019) · Reproductive Endocrinology · doi:10.18370/2309-4117.2019.50.12-16 · Cited by 3
Surgical menopause: A toolkit for healthcare professionals
Garg, A., & Robinson, L. L. L. (2021) · Post Reproductive Health · doi:10.1177/20533691211038455 · Cited by 3
Prämature Ovarialinsuffizienz (POI)
Rehnitz, J., & Strowitzki, T. (2021) · Der Gynäkologe · doi:10.1007/s00129-021-04802-8 · Cited by 3
Chionna, R., Salvatore, S., & Longhi, E. V. (2023) · Springer eBooks · doi:10.1007/978-3-031-31307-3_14 · Cited by 3
Hormone Replacement Therapy in a Patient with Hypogonadism and Coexisting Medical Conditions
Dural, Ö., & Poyrazoğlu, Ş. (2020) · Journal of Clinical Research in Pediatric Endocrinology · doi:10.4274/jcrpe.galenos.2020.2019.s0021 · Cited by 2
García-García, M., de León, D. F. C., Salcedo‐Hernández, R. A., González-Enciso, A., Sepúlveda-Rivera, C. M., González, J. C., & Barquet-Muñoz, S. A. (2022) · Journal of Obstetrics and Gynaecology · doi:10.1080/01443615.2022.2112026 · Cited by 2
Hormone Replacement Therapy in Women with POI: A Patient’s Perspective
Joachim, C. M. (2016) · Springer eBooks · doi:10.1007/978-3-319-22491-6_12 · Cited by 2
From Primary Hypergonadotropic Amenorrhea to “POI”: Aetiology and Therapy
Bruni, V., Bucciantini, S., & Ambroggio, S. (2017) · ISGE series · doi:10.1007/978-3-319-41433-1_7 · Cited by 2
Premature Ovarian Insufficiency
Goetsch, A. L., Kimelman, D., & Woodruff, T. K. (2017) · Springer eBooks · doi:10.1007/978-3-319-52316-3_11 · Cited by 2
Freel, E. M., & Mason, A. (2018) · Hypertension · doi:10.1161/hypertensionaha.118.12029 · Cited by 3
The ovarian immune pathology and reproductive failures
Wu, L., Fang, X., Wang, Y., & Kwak-Kim, J. Y.-H. (2022) · Elsevier eBooks · doi:10.1016/b978-0-323-90805-4.00018-3 · Cited by 1
Endocrine late-effects in survivors of childhood and adolescence cancer: clinical management
Biasin, E., Felicetti, F., Cattoni, A., Aloj, G., Giorgiani, G., Gorio, C., Haupt, R., Mastronuzzi, A., Muraca, M., Pillon, M., et al. (2026) · Journal of Endocrinological Investigation · doi:10.1007/s40618-026-02824-4 · Cited by 1
Benedetto, C., Khadilkar, S. S., Nappi, R. E., Genazzani, A. R., Frezet, F., Cucinella, L., Divakar, H., Anagnostis, P. G., & Panay, N. (2026) · International Journal of Gynecology & Obstetrics · doi:10.1002/ijgo.71217 · Cited by 1
Benedetto, C., Khadilkar, S. S., Nappi, R. E., Genazzani, A. R., Frezet, F., Cucinella, L., Divakar, H., Anagnostis, P. G., & Panay, N. (2026) · Climacteric · doi:10.1080/13697137.2026.2691828 · Cited by 2
Pacheco, J. (2011) · Anales de la Facultad de Medicina · doi:10.15381/anales.v71i3.94 · Cited by 1
Lessons from a patient with Turner syndrome
Turtle, E. J., Sule, A. A., Bath, L., Denvir, M. A., Gebbie, A. E., Mirsadraee, S., & Webb, D. J. (2013) · QJM · doi:10.1093/qjmed/hct056 · Cited by 1
Self-citationAnderson, R. A., Mitchell, R. T., Kelsey, T., Spears, N., Wallace, W. H., & Wallace, B. (2015) · Cited by 1
Self-citationThe Long-Term Cardiovascular Risks Associated with Amenorrhea
Simoncini, T., Giannini, A., & Genazzani, A. R. (2017) · ISGE series · doi:10.1007/978-3-319-41433-1_10 · Cited by 1
Arterial Hypertension in Turner Syndrome
Groote, K. D., Demulier, L., Backer, J. F. A. D., & Backer, T. L. M. D. (2018) · Updates in hypertension and cardiovascular protection · doi:10.1007/978-3-319-59918-2_12 · Cited by 1
Ochsner, H., Saner, F. A. M., Flück, C. E., Atlas, G., Wüest, A., Zacharin, M., & Saner, C. C. S. (2024) · Hormone Research in Paediatrics · doi:10.1159/000539697 · Cited by 1
McGlacken-Byrne, S. M., Gunn, H. M., & Simpson, H. (2024) · Endocrinology · doi:10.1007/978-3-030-23709-7_29 · Cited by 1
ESHRE Guideline: management of women with premature ovarian
Webber, L. J., Davies, M. C., Anderson, R. A., BARTLETT, J., Braat, D. D. M., Cartwright, B., Cífková, R., Keizer‐Schrama, S. D. M., Hogervorst, E., Janse, F., et al. (2016) · Cited by 1
Premature Ovarian Insufficiency: Practical Management Approaches
Tsiligiannis, S., Panay, N., & Stevenson, J. C. (2019) · ISGE series · doi:10.1007/978-3-030-14358-9_11 · Cited by 1
Premature Ovarian Insufficiency
Gunning, M. N., Troìa, L., Janse, F., Luisi, S. V., & Fauser, B. C. J. M. (2020) · Endocrinology · doi:10.1007/978-3-030-03594-5_15-1 · Cited by 1
PREMATURE OVARIAN FAILURE, ITS CONSEQUENCES, MORTALITY AND IMPACT ON THE CARDIOVASCULAR SYSTEM
Lopukhov, S. V., & Филиппов, Е. В. (2021) · Nauka molodykh (Eruditio Juvenium) · doi:10.23888/hmj202191147-156 · Cited by 1
Cattoni, A., Parissone, F., Porcari, I., Molinari, S., Masera, N., Franchi, M. P., Cesaro, S., Gaudino, R., Passoni, P., & Balduzzi, A. (2021) · Yearbook of pediatric endocrinology · doi:10.1530/ey.18.9.7 · Cited by 1
Early menopause: diagnosis and management
Glenn, T. L., & Kallen, A. N. (2021) · Elsevier eBooks · doi:10.1016/b978-0-12-822288-1.00009-9 · Cited by 1
Dowlut‐McElroy, T., & Shankar, R. K. (2023) · Hormone Research in Paediatrics · doi:10.1159/000530724 · Cited by 2
Treatment of premature ovarian failure
Cartwright, B. (2014) · Research Portal (King's College London) · Cited by 1
Swee, D. S., & Quinton, R. (2020) · Menopause The Journal of The North American Menopause Society · doi:10.1097/gme.0000000000001689 · Cited by 1
Hypogonadotropic hypogonadism in women: treatment options
Greenman, Y. (2013) · Reviews in Endocrinology and Metabolism · doi:10.11138/rem/2013.1.2.062
Reply: Physiological sex steroid replacement in premature ovarian failure
Critchley, H., Warner, P., O'Donnell, R. L., Bath, L., & Wallace, W. H. (2012) · Human Reproduction · doi:10.1093/humrep/des272
Self-citationHormone Therapy in Women with Premature Ovarian Failure: Is Transdermal Safer Than Oral?
Kaunitz, A. M. (2009) · Journal watch · doi:10.1056/wh200905210000001
The investigation of patients with hypertension: who might have a secondary cause?
Warren, R. E., & Padfield, P. L. (2010) · Clinical Risk · doi:10.1258/cr.2010.010021
Emerging Aspects of Turner Syndrome
Gravholt, C. H., Stochholm, K., Cleemann, L. H., & Mortensen, K. H. (2010) · touchREVIEWS in Endocrinology · doi:10.17925/ee.2011.07.01.58
The Role Of T Cells In Postmenopausal Hypertension
Pollow, D. P. (2016) · UA Campus Repository (The University of Arizona)
Hormonersatztherapie bei prämaturer Ovarialinsuffizienz
Strowitzki, T. (2017) · Der Gynäkologe · doi:10.1007/s00129-017-4095-2
Cardiovascular Risks of Impaired Fertility and Assisted Reproductive Therapy
Park, K. E., & Pepine, C. J. (2018) · Springer eBooks · doi:10.1007/978-3-319-71135-5_6
Management der prämaturen Ovarialinsuffizienz
Weidlinger, S., & Stute, P. (2018) · Gynäkologische Endokrinologie · doi:10.1007/s10304-018-0201-3
Шурпяк, С. А. (2018) · Reproductive Endocrinology · doi:10.18370/2309-4117.2018.41.48-54
Hormone Replacement Therapy in Premature Ovarian Insufficiency
Bruni, V., & Pampaloni, F. (2019) · ISGE series · doi:10.1007/978-3-030-14358-9_10 · Cited by 1
Premature Ovarian Insufficiency
Podfigurna, A., Grymowicz, M., Szeliga, A., Rudnicka, E., Maciejewska-Jeske, M., Smolarczyk, R., & Męczekalski, B. (2019) · Springer eBooks · doi:10.1007/978-3-030-13936-0_3
Estrogen Replacement in Turner Syndrome
Klein, K. O., Rosenfield, R. L., Santen, R. J., Gawlik, A., Backeljauw, P. F., Gravholt, C. H., Sas, T., & Mauras, N. (2020) · Springer eBooks · doi:10.1007/978-3-030-34150-3_5
Maintained Bone Density in Young Hypoestrogenized Women with a High BMI: Case Series
Rivas, A. C., Burt, L. A., Innes, M., Boyd, S. K., & Kline, G. A. (2021) · Calcified Tissue International · doi:10.1007/s00223-021-00857-w
Li, Z., Wang, S., Ren, J., Zhi, T., Wang, H., Zhu, Y., Wang, Y., Yao, Z., Zhang, H., Feng, J., et al. (2021) · Advances in Therapy · doi:10.1007/s12325-021-01869-6
Weidlinger, S. (2018) · Journal für Gynäkologische Endokrinologie/Schweiz · doi:10.1007/s41975-018-0045-1
Ge, X.-F., Li, S.-S., Liu, Y., Lu, M., Su, H., Yang, X., & Sun, X. (2022) · Chinese Journal of Integrative Medicine · doi:10.1007/s11655-022-3514-3
Management clinico e terapia sostitutiva dell’insufficienza ovarica primaria
Federici, S., Bonomi, M., & Persani, L. (2023) · L Endocrinologo · doi:10.1007/s40619-023-01227-4
Hormondiagnostik in der Peri- und Postmenopause – Schritt für Schritt
Tempfer, C. M., & Hecken, J. M. (2023) · Frauenheilkunde up2date · doi:10.1055/a-1838-0838
Well-Woman Care for the Female Cancer Survivor
Nguyen, N. T. T., Selter, J. H., Kuller, J. A., & Acharya, K. S. (2023) · Topics in Obstetrics & Gynecology · doi:10.1097/01.pgo.0000905644.97691.f4
Primary ovarian insufficiency- An overview: Part 2 diagnosis and management
Mondal, R., Nandi, M., & Mandal, P. (2023) · Indian Journal of Obstetrics and Gynecology Research · doi:10.18231/j.ijogr.2023.074
McGlacken-Byrne, S. M., Gunn, H. M., & Simpson, H. (2023) · Endocrinology · doi:10.1007/978-3-030-18901-3_29-1
Premature Ovarian Insufficiency
Gardner, A. B., & Campbell, S. B. (2024) · Cambridge University Press eBooks · doi:10.1017/9781009279864.005
Premature ovarian insufficiency (POI) in childhood cancer survivors
Gunasheela, D., & Veerambudhi, A. M. (2024) · The Onco Fertility Journal · doi:10.4103/tofj.tofj_4_23
Premature Ovarian Insufficiency in Patients with Autoimmune Diseases
Karachentsova, I. V., Sibirskaya, E. V., Krainova, U. A., Mospan, V. D., & Chernysheva, M. Y. (2025) · Педиатрическая фармакология · doi:10.15690/pf.v22i3.2916
Premature ovarian insufficiency: An update. A literature review
Abdelhafez, M. M., Ahmed, K. A. M., Ahmed, N. A. M., Ismail, M. H., Daud, M. N., Eldiasty, A., Amri, M. F., Jeffree, M. S., Kadir, F., Baharuddin, D. M. P., et al. (2025) · Clínica e Investigación en Ginecología y Obstetricia · doi:10.1016/j.gine.2025.101071
Yang, D., Tao, S., 邵明晶, Huang, L., Xiao, X., Zhang, J., Yao, R., & Sun, Z. (2024) · Figshare · doi:10.6084/m9.figshare.26157115
Cai, W.-Y., Luo, X., Wu, W., Song, J., Xie, N.-N., Duan, C., Wu, X.-K., & Xu, J. (2022) · Figshare · doi:10.6084/m9.figshare.21256864
Yang, D., Tao, S., 邵明晶, Huang, L., Xiao, X., Zhang, J., Yao, R., & Sun, Z. (2024) · Figshare · doi:10.6084/m9.figshare.26157377
Cai, W.-Y., Luo, X., Wu, W., Song, J., Xie, N.-N., Duan, C., Wu, X.-K., & Xu, J. (2022) · Figshare · doi:10.6084/m9.figshare.21256870
Cai, W.-Y., Luo, X., Wu, W., Song, J., Xie, N.-N., Duan, C., Wu, X.-K., & Xu, J. (2022) · Figshare · doi:10.6084/m9.figshare.21256867
Cai, W.-Y., Luo, X., Wu, W., Song, J., Xie, N.-N., Duan, C., Wu, X.-K., & Xu, J. (2022) · Figshare · doi:10.6084/m9.figshare.21256873
Persani, L., Federici, S., & Dorato, E. (2026) · Elsevier eBooks · doi:10.1016/b978-0-443-13825-6.00370-8
Zhou, W.-S., Li, Y., Xu, N., Liu, B.-F., Li, Z.-H., Gu, S.-J., Zhang, R.-Y., Xuan-Xu, Yan, C., Wang, Q.-Y., et al. (2026) · Scientific Reports · doi:10.1038/s41598-026-36835-1
Zheng, W., Fang, Z., Cai, T., Zhang, R., Wang, N., Chen, R., Lin, B., & Nian, J. (2026) · BMC Women s Health · doi:10.1186/s12905-026-04477-0
Metadata
- Authors
- Langrish, J. P., Mills, N. L., Bath, L. E., Warner, P., Webb, D. J., Kelnar, C. J., Critchley, H. O. D., Newby, D. E., & Wallace, W. H. B.
- Affiliations
- University of Edinburgh (GB)
- ORCID
- Venue
- Hypertension
- Published
- 2009-05
- Volume
- 53
- Issue
- 5
- Pages
- 805-811
- ISSN
- 0194-911X (ISSN-L)
- 1524-4563
- OpenAlex
- W2161581155
- Cited by
- 207
- References
- 37
- Citations by year
- 2026: 12 · 2025: 7 · 2024: 16 · 2023: 15 · 2022: 20 · 2021: 16 · 2020: 16 · 2019: 20 · 2018: 16 · 2017: 15 · 2016: 10 · 2015: 6 · 2014: 4 · 2013: 5 · 2012: 9
- FWCI
- 7.02
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Hypertension (publishedVersion)
- PubMed (publishedVersion)
- Funders
- British Heart Foundation (FS/07/048)
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Menopause: Health Impacts and Treatments
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Hormonal and reproductive studies
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Endocrinology › Estrogen and related hormone effects
- Keywords
- premature ovarian failure, sex hormone replacement therapy, transdermal estradiol, vaginal progesterone, ethinyl estradiol, norethisterone, cardiovascular health, blood pressure, arterial stiffness, renin-angiotensin system, angiotensin II, aldosterone, renal function, luteinizing hormone suppression, follicle-stimulating hormone
- MeSH terms
- Adult, Arteries, Blood Pressure, Female, Humans, Estrogen Replacement Therapy, Primary Ovarian Insufficiency, Cross-Over Studies, Blood Pressure Monitoring, Ambulatory
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review